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Behavioural changeWe report a family with a novel CSF1Rmutation causing hereditary diffuse leucoencephalopathy with axonal
spheroids. Family members presented with neuropsychiatric and behavioural symptoms, with subsequent
development of motor symptoms and gait disturbance. MRI brain showed extensive white matter change
with a frontal predominance and associated atrophy in two members of the family. Genetic testing revealed
a novel mutation c.2342C > T (p.A781V) in the CSF1R gene in two brothers of the family. This report high-
lights the difﬁculties in diagnosing HDLS and discusses the indications for testing for mutations in the
CSF1R gene.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Mutations in the colony stimulating factor 1 receptor gene (CSF1R)
have recently been shown to cause hereditary diffuse leukoenceph-
alopathy with axonal spheroids (HDLS) [1]. Typically, patients present
with personality change and neuropsychiatric symptoms, followed by
cognitive decline and motor impairment particularly affecting gait [2].
There is phenotypic heterogeneity and patients have been diagnosed in
lifewith a variety of different neurological diagnoses includingAlzheimer's
disease, frontotemporal dementia, atypical parkinsonism, multiple sclero-
sis and small vessel cerebrovascular disease. [1,2]We report a novelmuta-
tion in the CSF1R gene in a family with an autosomal dominant dementia
with prominent behavioural cognitive symptoms.
2. Case report
DRC155 is a family from the UK with an autosomal dominant his-
tory of dementia (Fig. 1 — family tree). Five of seven siblings were, Institute of Neurology, Queen
B.V. Open access under CC BY-NC-ND laffected. Both parents were said to be cognitively normal prior to
their deaths at age 61 years and 71 years, however their young age
of death may have concealed a diagnosis of dementia.2.1. Sibling 1.5
This gentleman presented at the age of 54-years-old with a six
year history of depression and anxiety. He had been working as a
piano maker and over the previous few years had increasing difﬁcul-
ties with his work. Over a similar time period his mobility had be-
come worse and he felt slow and unsteady whilst walking. More
recently he developed problems with episodic memory over the pre-
vious year and difﬁculty speaking over the last six months. His wife
felt that there had been a recent change in his personality with apa-
thy, irritability and socially inappropriate behaviour. On examination
he scored 26/30 on MMSE and was noted to be bradyphrenic. Cranial
nerve territory examination was normal but in the limbs he had
increased tone throughout with brisk reﬂexes, although normal
power. His gait was broad-based and slow. Neuropsychometry re-
vealed severely impaired executive function with some impairment
of verbal recognition memory as well. MRI brain (Fig. 2) showed
white matter change and atrophy which was widespread but with a
frontal predominance. There was also involvement of the corpus
callosum with associated atrophy.icense.
Fig. 1. Family pedigree. Black colour indicates affected by dementia.
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This patient the brother of 1.5was assessed at the age of 67 yearswith
difﬁculty walking and slowing of movements. Cognitively his family had
not noticed any deﬁcits, but on neurophysiological examination he had
reduced executive function and problems with visuo-constructional
skills, suggesting moderate cognitive impairment affecting the anterior
regions. On neurological examination he had increased tone throughout
and clonus affecting the left ankle, power and reﬂexes were normal. On
gait examination he was felt to be slowed and dragging his left foot.
MRI of the brain showed global atrophy and enlarged ventricles with
extensive white matter change affecting the parietal and frontal lobes,
there was thinning of the corpus callosummore marked posteriorly.
2.3. Sibling 1.3
The brother of 1.5 had been assessed at the age of 58 with a 2 year
history of behavioural change which was predominantly apathy with
self-neglect. He also had a gait disorder which started around the
same time as the behavioural change. On examination he was noted
to be bradyphrenic; cranial nerve examination was normal. He hadFig. 2. MR imaging of 1.5 showing widespread white matter change with a frontal pincreased tone throughout the limbs, but normal power and reﬂexes.
His gait was broad based and slow. CT imaging was reported as show-
ing generalised cerebral atrophy of central and cortical grey matter,
with widespread white matter low density, both in the white matter
and around the bodies of the lateral ventricles. An FDG-PET scan showed
a reduction in cerebral glucose uptake, with an anterior–posterior gradi-
ent with hypometabolism more marked in the frontal lobes. He was
given a provisional diagnosis of a frontal lobe dementing illness.
2.4. Sibling 1.2
Another brother had been diagnosed with a young onset demen-
tia, most likely Alzheimer's disease, although no other information
was available. He had an age of onset of 32-years-old and had died
four years later at the age of 36.
2.5. Sibling 1.1
The eldest of the siblings also had a young onset dementia and was
given a diagnosis of Alzheimer's disease and had died at age 60. No fur-
ther information was available.
3. Genetic analysis
A blood sample was available from patients 1.5 and 1.7 for genetic
analysis. ExonPrimer was used to generate primers for ampliﬁcation
of CSF1R exons 1 to 22 plus exon–intron boundaries (primer sequences
available on request). These exons were PCR ampliﬁed using Roche
FastStart PCR Master Mix polymerase (Roche Diagnostics Corp., IN) or
Roche FastStart PCR Master Mix polymerase plus Dimethyl sulfoxide
(DMSO) (Qiagen, CA, USA), 15 ng of genomic DNA and the respective
forward and reverse primers. The PCR ampliﬁcation products were
cleaned and approximately 15 ng of each PCR productwas used as tem-
plate per sequencing reaction containing 5× Reaction Buffer, BigDye®
(Applied Biosystems) and the forward or reverse primer that was
used for ampliﬁcation of the original product. Sequencing reactions
were cleaned and sequencing was performed on an ABI 3730 DNAredominance. There is associated atrophy and thinning of the corpus callosum.
Fig. 4. Distribution of all the mutations described so far in the three-dimensional struc-
ture of the tyrosine kinase domain of the CSF1R protein, including the mutation here
identiﬁed (p.A781V). Protein representation made using the Protein Workshop [11].
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Sequencher (version 4.2 Gene Codes Corporation) and variants were
named based on sequences with accession numbers NM_005211.3
and NP_005202.2. A novel c.2342C > T (p.A781V) mutation was found in
exon 18. In silico analysis of pathogenicity using PROVEAN (Protein
Variation Effect Analyzer) v.1.1 [3] and PolyPhen-2 (Polymorphism
Phenotyping v2) [4] tools predicted CSF1R p.A781V mutation to be
pathogenic (PROVEAN: deleterious with score of −3.332 and
PolyPhen: probably damaging with a score of 1.0).
4. Discussion
28 different mutations have now been described in the CSF1R gene
causing an autosomal dominant disorder with neuropsychiatric and
behavioural symptoms followed by cognitive and motor impairment
[1,2,5–9]. The family that we report is consistent with previous
descriptions with a predominantly behavioural syndrome at presen-
tation. Imaging features in patients with CSF1R gene mutations are
usually T2 hyperintense foci in the periventricular deep and subcorti-
cal frontal and bifrontal cerebral white matter that may be asymmet-
ric, with involvement of the corpus callosum and corticospinal tracts
[10]. This is similar to what was found in the three members of the
reported family that were scanned at our institution, including atro-
phy that was predominantly frontal and in the corpus callosum.
Although complete segregation analysis was not possible, as DNA
was available for only two affected siblings, several facts lead us to con-
clude that this mutation is most likely pathogenic: 1) it has not been
reported in the large-scale genome and exome sequencing databases
(dbSNP132, 1000 Genomes Project, March 2012 release and the
NHLBI Exome Sequencing Project); 2) it is predicted by different predic-
tion tools (PROVEAN and PolyPhen-2) to be damaging to the protein;
and 3) the residue mutated is highly conserved between species (see
Fig. 3) and it is located in the tyrosine kinase domain of the CSF1R
gene, where all pathogenic mutations previously identiﬁed have been
described (Fig. 4).
This report highlights the difﬁculty in diagnosing HDLS antemor-
tem. Prior to genetic testing in the current family two of the siblings
were given a diagnosis of Alzheimer's disease and one of frontal
lobe degeneration. Testing for the CSF1R gene mutation now provides
a deﬁnitive diagnosis and we recommend testing for this in patientsFig. 3. Molecular analysis of CSF1R. A novel heterozygous mutation (c.2342C > T, p.A781V)
starting at the translation initiation codon and NP_005202.2, respectively. Protein sequence
this residue of the CSF1R protein is highly conserved between species.with a typical history, particularly when behavioural and cognitive
symptoms are predominant with associated gait problems, and
white matter changes that have a frontal predominance and involve-
ment of the corpus callosum.Author contribution
Rebekah Ahmed, Jonathan Rohrer, Martin Rossor, and Nick Fox —
patient review and manuscript preparation.
Rita Guerreiro, Gamze Guven, John Hardy: genetic testing, sequenc-
ing of mutation, manuscript preparation.was found in exon 18 of CSF1R. cDNA and protein references used were NM_005211.3
alignment around the mutation site (A781) is shown for different CSF1R orthologues:
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